Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Other Non-Current Liabilities: 2020-2025

Historic Other Non-Current Liabilities for Legend Biotech (LEGN) over the last 4 years, with Sep 2025 value amounting to $8.1 million.

  • Legend Biotech's Other Non-Current Liabilities rose 28117.24% to $8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year increase of 28117.24%. This contributed to the annual value of $56,000 for FY2023, which is 75.97% down from last year.
  • Latest data reveals that Legend Biotech reported Other Non-Current Liabilities of $8.1 million as of Q3 2025, which was up 28,117.24% from -$29,000 recorded in Q3 2024.
  • In the past 5 years, Legend Biotech's Other Non-Current Liabilities ranged from a high of $8.1 million in Q3 2025 and a low of -$1.2 million during Q3 2023.
  • In the last 3 years, Legend Biotech's Other Non-Current Liabilities had a median value of -$11,500 in 2023 and averaged $857,500.
  • As far as peak fluctuations go, Legend Biotech's Other Non-Current Liabilities spiked by 64,159.93% in 2022, and later slumped by 918.85% in 2023.
  • Legend Biotech's Other Non-Current Liabilities (Quarterly) stood at $396,000 in 2021, then tumbled by 41.16% to $233,000 in 2022, then slumped by 75.97% to $56,000 in 2023, then surged by 97.67% to -$29,000 in 2024, then surged by 28,117.24% to $8.1 million in 2025.
  • Its Other Non-Current Liabilities was $8.1 million in Q3 2025, compared to -$29,000 in Q3 2024 and -$56,000 in Q2 2024.